Indications for medical antibiotic prophylaxis and potential targets for antimicrobial stewardship intervention: a narrative review. (March 2022)

• Record Type: Journal Article
• Authors: Ioannou, Petros; Karakonstantis, Stamatis; Schouten, Jeroen; Kostyanev, Tomislav; Charani, Esmita; Vlahovic-Palcevski, Vera; Kofteridis, Diamantis P.
• Is Part Of: Clinical microbiology and infection. Volume 28:Number 3(2022)
• Page Start: 362
• Page End: 370
• Publication Date: 2022-03
• Subjects: Antibiotic prophylaxis -- Antimicrobial resistance -- Antimicrobial stewardship -- Drug resistance -- Microbial; Medical microbiology -- Periodicals; Diagnostic microbiology -- Periodicals; Communicable diseases -- Periodicals; Infection -- Periodicals; 616.01
• DOI: 10.1016/j.cmi.2021.10.001
• Languages: English
• ISSNs: 1198-743X

Abstract

Abstract: Background: Most of the antimicrobial stewardship (AMS) literature has focused on antimicrobial consumption for the treatment of infections, for the prophylaxis of surgical site infection and for the prevention of endocarditis. The role of AMS for medical antibiotic prophylaxis (AP) has not been adequately addressed. Aims: To identify targets for AMS interventions for medical AP in adult patients. Sources: Targeted searches were conducted in PubMed. Content: The various indications for medical AP and relevant evidence from practice guidelines are outlined. The following were identified as potential targets for AMS interventions: (a) addressing under-utilization of antibiotic-sparing strategies (e.g. for recurrent urinary tract infections, recurrent soft-tissue infections, recurrent exacerbations associated with bronchiectasis or chronic obstructive pulmonary disease), (b) reducing unnecessary AP beyond recommended indications (e.g. for acute pancreatitis, bite wounds, or urinary catheter manipulations), (c) reducing the use of AP with a broader spectrum than necessary, (d) reducing the use of AP for longer than the recommended duration (e.g. AP for prevention of osteomyelitis in open fractures or AP in high-risk neutropenia), (e) evaluating the role of antibiotic cycling to prevent the emergence of resistance during prolonged AP (e.g. in recurrent urinary tract infections or prophylaxis for spontaneous bacterial peritonitis), and (f) addressing research gaps regarding appropriate indications or antibiotic regimens for medical prophylaxis. Implications: This review summarizes current trends in AP and proposes targets for AMS interventions.